A New Pharmacokinetic Model for 90y-Ibritumomab Tiuxetan Based on 3-Dimensional Dosimetry

Scientific Reports - United Kingdom
doi 10.1038/s41598-018-33160-0
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

MIRD Dose Estimate Report No. 20: Radiation Absorbed-Dose Estimates for 111In- And 90y-Ibritumomab Tiuxetan

Journal of Nuclear Medicine
MedicineNuclear MedicineRadiologyImaging
2009English

Positron Emission Tomography/Computed Tomography Before Treatment as a Predictor of 90y-Ibritumomab Tiuxetan Response

Kitakanto Medical Journal
Medicine
2018English

Full-Dose 90Y Ibritumomab Tiuxetan Therapy Is Safe in Patients With Prior Myeloablative Chemotherapy

Clinical Cancer Research
Cancer ResearchOncology
2005English

P53-Based Strategy for Protection of Bone Marrow From Y-90 Ibritumomab Tiuxetan

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2015English

Radioimmunotherapy for B-Cell Lymphoma: Y90 Ibritumomab Tiuxetan and I131 Tositumomab

Oncogene
Cancer ResearchGeneticsMolecular Biology
2007English

Radioimmunotherapy With 90y-Ibritumomab Tiuxetan Is a Safe and Efficient Treatment for Patients With B-Cell Lymphoma Relapsed After Auto-Sct: An Analysis of the International RIT-Network

Bone Marrow Transplantation
TransplantationHematology
2010English

SPECT/CT 90y-Bremsstrahlung Images for Dosimetry During Therapy

ecancermedicalscience
Cancer ResearchOncology
2009English

A Physiologically-Based Pharmacokinetic Model for Vancomycin

SIAM Undergraduate Research Online
2016English

Partition Model-Based 99mTc-Maa SPECT/CT Predictive Dosimetry Compared With 90Y TOF PET/CT Posttreatment Dosimetry in Radioembolization of Hepatocellular Carcinoma: A Quantitative Agreement Comparison

Journal of Nuclear Medicine
MedicineNuclear MedicineRadiologyImaging
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy